Available until 12 May 2026.
Following the recent news that the GLP-1 agonist tirzepatide has been approved by NICE for use outside of hospital settings, this evening webinar aims to enhance understanding of these medications and looks at the way in which they may affect your day-to-day practice. Including prescribing process and logistical elements which you may face as a GP.
Not only will we look at prescribing but also factor into us all seeing more and more patients walk through our doors using weight loss injections privately. These talks will help you better understand all the considerations for providing weight loss injections and provide useful take home tips and updates around what to discuss with patients, including lifestyle advice.
Learning Objectives:
- Understand GLP-1 agonists currently for patients living with obesity
- Discuss potential benefits, risks and side effects of these medications
- Understand the prescribing process, including up-titration and considerations for other medications
- Review the NICE eligibility criteria and the NHSE funding variation


